Nurix therapeutics presents new preclinical data supporting nx-2127 and detil-0255 clinical programs at the american association for cancer research annual meeting

Studies provide insight into bifunctional molecular mechanism and first in vivo demonstration of immunomodulatory imide drug (imid) activity of nx-2127, resulting in robust tumor cell killing
NRIX Ratings Summary
NRIX Quant Ranking